2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)cancer, neoplasmActive, not recruitingPhase 32026-10-08NCT03148418
Pilot Study of The EPIC TrialInfections, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, paranasal sinus disorder, polyp, respiratory system disorder, respiratory tract infectious disorder, sinusitisActive, not recruitingNot applicable2025-12-30NCT02533206